Strategent Financial, LLC has filed a Form 13F-HR with the U.S. Securities and Exchange Commission, disclosing its equity holdings as of September 30, 2026. The filing indicates that the firm holds positions in 42 different securities.
The largest position disclosed in the portfolio is the Dimensional ETF Trust International Core Equity ETF, which holds 202,793 shares. This is followed by the Dimensional ETF Trust US Large Value ETF, with 110,952 shares, and the Dimensional ETF Trust Emerging Markets Core Equity ETF, with 110,070 shares.
Other significant holdings include the American Century ETF Trust US Large Cap Value ETF (102,450 shares), the Invesco Exchange Traded Fund Trust II Nasdaq 100 ETF (48,988 shares), and the SPDR Series Trust S&P 500 ETF (96,724 shares). The portfolio also includes substantial positions in Dimensional ETF Trust funds focused on small-cap equities, international small-cap equities, and targeted value strategies.
Individual stock holdings include AbbVie Inc. (783 shares), Alphabet Inc. Class A (1,326 shares), Apple Inc. (1,474 shares), Berkshire Hathaway Inc. Class B (1,635 shares), Johnson & Johnson (2,184 shares), Markel Group Inc. (853 shares), McKesson Corp. (283 shares), Merck & Co. Inc. (3,034 shares), and Microsoft Corp. (1,547 shares).
The filing lists Dale S. Lam, the President of Strategent Financial, as the authorized signatory for the report.
